MiRNA-875-3p alleviates the progression of colorectal cancer via negatively regulating PLK1 level
Authors: L-M Tian
J-Y Li
S-S Li
D-M Lv
H-J Zhu
Journal: European review for medical and pharmacological sciences (2020)
Discipline: PHARMACOLOGY & TOXICOLOGY
Keywords: miRNA-875-3p; CRC; progression; regulatory effect; expression pattern
Affiliations: Department of General Surgery, Xi'an Central Hospital, Xi'an, China. .

Abstract:  Objective: To clarify the expression pattern of miRNA-875-3p in CRC and its potential regulatory effect on the progression of CRC. Materials and methods: MiRNA-875-3p level in 56 matched CRC tissues and adjacent normal tissues were determined. The correlation between the miRNA-875-3p level and pathological indexes of CRC patients was analyzed. Prognostic potential of miRNA-875-3p in CRC patients was assessed by introducing the Kaplan-Meier curves. Influences of miRNA-875-3p on viability, migration, and wound closure were assessed through a series of functional experiments. The interaction between miRNA-875-3p and PLK1 in regulating the progression of CRC was finally uncovered by Dual-Luciferase reporter gene and rescue experiments. Results: MiRNA-875-3p was downregulated in CRC tissues and cell lines. CRC patients with low level of miRNA-875-3p suffered a higher rate of distant metastasis and worse prognosis. Overexpression of miRNA-875-3p attenuated proliferative and migratory capacities of SW480 and HT29 cells. PLK1 was confirmed to be the target gene of miRNA-875-3p. PLK1 was upregulated in CRC tissues and cell lines, which was negatively regulated by miRNA-875-3p. MiRNA-875-3p alleviated the malignant progression of CRC via negatively regulating PLK1. Conclusions: MiRNA-875-3p is downregulated in CRC, which is closely related to distant metastasis and poor prognosis of CRC patients. MiRNA-875-3p alleviates the progression of CRC through targeting and downregulating PLK1. 

Retracted: No

PubPeer comments:
 This paper is part of a group of papers with a characteristic Kaplan Meier curve with a comb-like appearance. These plots all have a drop to 0 % survival at 75 months, a.k.a  Hoya s Law . Within the Comb papers, there is a subgroup of at least 9 papers that have very similar negative correlation plots. * X Shi et al., ERMPS (2019), DOI: 10.26355 eurrev_201912_19778 - https: pubpeer.com publications 3133C4267A6FBF81D00B0AF9FB9F2C * CY Yang et al., ERMPS (2019), DOI: 10.26355 eurrev_201908_18736 - https: pubpeer.com publications 04A58FD5AFBB311D1A2938B0612E1E * HG Zhang et al., ERMPS (2019), DOI: 10.26355 eurrev_201903_17239 - https: pubpeer.com publications D916E15502393940A4F3151E1D300C * JY Chen et al, ERMPS (2020), DOI: 10.26355 eurrev_202001_20040 - https: pubpeer.com publications 9266A736E004B8D7C32F6811161C1C * SS Li et al., ERMPS (2020) - DOI: 10.26355 eurrev_202002_20163 - https: pubpeer.com publications 5CDE9845135F510EC218243CD501F9 * TZ Zheng et al., ERMPS (2020) - DOI: 10.26355 eurrev_202002_20369 - https: pubpeer.com publications AF0159381E48D7937D78C948FAB379 * JB Ma et al., ERMPS (2019) - DOI: 10.26355 eurrev_201902_17108 - https: pubpeer.com publications 2EB1B6A17E9877F2D7F8FE4E117446 * HW Sun et al., ERMPS (2019)- DOI: 10.26355 eurrev_201910_19299 - https: pubpeer.com publications 937B0CAD1A01B66E854F4A6CCDA56B * K Jia et al., ERMPS (2020) - DOI: 10.26355 eurrev_202003_20508 - https: pubpeer.com publications 11550517E8A0503AFDC49D460BAD30 And here is a collage of the nine correlation plots, where I have circled some similar groupings of points.  , 
 #1 Fig 1C.  Kaplan-Meier curves revealed overall survival in CRC patients expressing high or low level of miR-875-3p.  , 
 #1 Fig 3F:  Negative correlation between expression levels of miR-875-3p and PLK1 in CRC tissues. At right, a superimposition of 11 variations of this scatterplot (the nine above, along with two more). Data points are darker if they appear in more variations.  ,